Gerhard Seipke
14Patents
9h-index
21Co-inventors
72Inventor score
Filing activity: Aug 11, 1983 → Jun 22, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6221633A | Insulin derivatives having a rapid onset of action | Chemistry; Metallurgy | 80 | Expired |
| US5270176A | Method for the selective cleavage of fusion proteins with lysostaphin | Chemistry; Metallurgy | 41 | Expired |
| US6221837A | Insulin derivatives with increased zinc binding | Human Necessities | 29 | Expired |
| US4644057A | Process for the cleavage of peptides and proteins at the methionyl bond using cyanogen chloride | Emerging Cross-Sectional Technologies | 26 | Expired |
| US6875589B1 | Mini-proinsulin, its preparation and use | Human Necessities | 23 | Expired |
| US8633156B2 | Insulin derivatives having an extremely delayed time-action profile | Human Necessities | 17 | Active |
| US4526717A | Polypeptide having an action on the immunological system, processes for its isolation and purification, its use, agents containing this compound, and its cleavage products, their use and agents containing these products | Emerging Cross-Sectional Technologies | 12 | Expired |
| US4500450A | Polypeptide having an action on the immunological system, process for its isolation and purification, its use, agents containing this compound, and its cleavage products, their use and agents containing these products | Emerging Cross-Sectional Technologies | 11 | Expired |
| US5674531A | Nanoparticles containing an active substance and a ketalized polytartramidic acid, process for their preparation, and use thereof | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6686177B1 | Insulin analogs with enhanced zinc binding | Human Necessities | 9 | Expired |
| US6534288B1 | C peptide for improved preparation of insulin and insulin analogs | Chemistry; Metallurgy | 7 | Expired |
| US4601852A | Process for the preparation of human or the derivatives thereof from pig insulin or the derivatives thereof | Chemistry; Metallurgy | 6 | Expired |
| US8603970B2 | Insulin derivatives having an extremely delayed time-action profile | General | 0 | Revoked |
| US9644017B2 | Insulin derivatives having an extremely delayed time-action profile | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.